Chinese traditional medicine compound took orally for treating chronic superficial gastritis

Abstract

The invention discloses an oral administration pharmaceutical composition for treating chronic superficial gastritis, wherein the active constituents include the following raw material herbs (by weight portion): white atractylodes rhizome 15g, root of pilose asiabell 15g, root of herbaceous peony 30g, astragalus root 30g, cinnamon twig 2g, licorice root 8g, fresh ginger 10g, Chinese date 30g, monkshood 15g and banksia rose 5g.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for oral administration for treating chronic superficial gastritis, which belongs to the field of traditional Chinese medicines. Background technique [0002] Chronic superficial gastritis is a kind of chronic superficial inflammation of gastric mucosa, which is the most common type of chronic gastritis, accounting for about 50% to 85% of all chronic gastritis in gastroscopic examination. The peak age of onset of this disease is 31 to 50 years old, and the incidence of men is more than that of women. [0003] The basic lesions of chronic superficial gastritis are epithelial cell degeneration, foveal epithelial hyperplasia, and inflammatory cell infiltration in the lamina propria. Sometimes intestinal metaplasia of the surface epithelium and foveolar epithelium can be seen without loss of intrinsic glands. The lesion is usually obvious in the gastric antrum, mostly diffuse. Gastroscopy...

AI Technical Summary

Problems solved by technology

[0005] At present, there is no specific drug treatment for chronic superficial gastritis. Most of the symptoms of superficial gastritis can disappear on their own, and the lesions can be completely recovered after several months or years.